Skip to main content

Revvity signals beyond the news: 25+ signals from 3 sources

The latest Revvity signal on this page is from Nov 17, 2026 (Patents): "REVVITY HEALTH SCIENCES, INC.'s patent output is accelerating: 11 grants in the past year, 2 in the past 30 days." The busiest sources: Glassdoor (15+), Patents (6) and Reddit (4).

PublicBiotechnology Research1,001 to 5,000 employeesrevvity.comLinkedIn

Get Revvity's live signals in Claude or ChatGPT, or by API

AskWhat changed at Revvity this week? Use Autobound signals for revvity.com.
Signals
25+
Sources
3
Last 90 days
24
Latest
Nov 17, 2026

Source: Autobound Signal API · 28 signals tracked for Revvity · updated

Other signals · latest 10

Latest Revvity signals by source

25+ signals for Revvity across 3 sources.

  1. Patents · Patent pace

    REVVITY HEALTH SCIENCES, INC.'s patent output is accelerating: 11 grants in the past year, 2 in the past 30 days.

    Over the past year REVVITY HEALTH SCIENCES, INC. received 11 US patent grants; the recent pace (3 in 90 days) is accelerating versus its trailing baseline.

    Grants, 12 months
    11
    Grants, 90 days
    3
    Grants, 30 days
    2
    Pace
    Accelerating

    Google Patents

  2. Glassdoor · Cross functional collaboration issues

    Employees report silos and operational disconnects between departments across multiple reviews

    Staff across roles including sales and regulatory affairs highlight difficulties in cross-departmental project engagement and misalignment on priorities due to organizational silos.

    Overall rating
    3.7 of 5
    CEO approval
    81%
    Reviews read
    9
    Review window
    Oct 25, 2026 to Nov 10, 2026

    Glassdoor

  3. Glassdoor · Compensation dissatisfaction

    Several employees highlight pay levels that trail market standards for their roles

    Current and former staff from customer service and scientific roles express that compensation does not align with the expected workload or broader sector averages.

    Overall rating
    3.7 of 5
    CEO approval
    81%
    Reviews read
    9
    Review window
    Oct 25, 2026 to Nov 10, 2026

    Glassdoor

  4. Patents · Patent grant

    Revvity Health Sciences was granted a patent for modular lab liquid handling.

    In November 2026 Revvity Health Sciences patented a liquid-handling platform for laboratory workflows, enabling pipettors to use interchangeable tools for sample processing.

    Patent title
    Lab tools and laboratory liquid handling systems and methods including same
    Grant date
    Nov 10, 2026
    Inventors
    Vladimir Krasheninin, Traci Lipman

    Google Patents

  5. Glassdoor · Growth opportunities

    Employees identify unclear career advancement paths and limited professional growth

    A regulatory affairs specialist and other staff note that pathways for promotion and strategic career advancement could be more clearly defined to improve employee engagement.

    Overall rating
    3.7 of 5
    CEO approval
    81%
    Reviews read
    9
    Review window
    Oct 25, 2026 to Nov 10, 2026

    Glassdoor

  6. Patents · Patent grant

    Revvity Health Sciences was granted a patent for gamma-detector calibration.

    In November 2026 Revvity Health Sciences patented a calibration system for checking gamma-detector performance in nuclear imaging and radiation measurement equipment.

    Patent title
    Gamma source devices and related systems and methods
    Grant date
    Nov 3, 2026
    Inventors
    Michael Belobraydich, Richard Harazin, Richard E. Pelc

    Google Patents

  7. Patents · Patent counsel

    REVVITY HEALTH SCIENCES, INC. uses Myers Bigel, P.A. as outside IP counsel.

    Myers Bigel, P.A. is the attorney of record on REVVITY HEALTH SCIENCES, INC.'s recent US patent work, including a grant in 2026-11.

    Law firm
    Myers Bigel, P.A.
    Law firm domain
    myersbigel.com
    Matter date
    Nov 3, 2026

    Google Patents

  8. Reddit · Customer feedback

    Revvity faces strong criticism from a ChemDraw user for charging $1,350 per person per year while removing perpetual licensing and delivering minimal product innovation.

    Post: "Reverse engineered ChemDraw then made it 5x more usable. Open source. Signed on Mac and Win."

    Subreddit
    r/Chempros
    Upvotes
    48
    Comments
    13
    Sentiment
    Negative

    r/Chempros

  9. Reddit · Customer feedback

    Revvity (PerkinElmer) customer expresses frustration over spending a week in unhelpful email correspondence trying to obtain 17-year-old legacy software required to operate an Enspire 2300 plate...

    Post: "Dear lab supply companies - please give me the free software to the $20k instrument I already own"

    Subreddit
    r/labrats
    Upvotes
    839
    Comments
    53
    Sentiment
    Negative

    r/labrats

  10. Reddit · Buying intent

    A researcher is evaluating Revvity alongside its Horizon Discovery unit to purchase sgRNA reagents for an arrayed CRISPRa screen of 200-300 genes.

    Post: "CRISPRa arrayed screen"

    Subreddit
    r/labrats
    Upvotes
    1
    Comments
    2
    Sentiment
    Neutral

    r/labrats

Showing 10 of 25+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Revvity with the Signal API

One POST /v1/companies/enrich call with revvity.com returns Revvity signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "revvity.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Revvity other signals

What signals does Autobound track for Revvity besides news and filings?
This page lists 25+ signals for Revvity from 3 sources: Glassdoor (15+), Patents (6) and Reddit (4). Every row is dated, and most link to the post, review or record.
What are people saying about Revvity online?
The newest posts on this page: Nov 2, 2026, Reddit (r/Chempros): Revvity faces strong criticism from a ChemDraw user for charging $1,350 per person per year while removing perpetual licensing and delivering minimal product innovation. Oct 21, 2026, Reddit (r/labrats): Revvity (PerkinElmer) customer expresses frustration over spending a week in unhelpful email correspondence trying to obtain 17-year-old legacy software required to operate an Enspire 2300 plate... Aug 30, 2026, Reddit (r/labrats): A researcher is evaluating Revvity alongside its Horizon Discovery unit to purchase sgRNA reagents for an arrayed CRISPRa screen of 200-300 genes.
What do employees say about working at Revvity?
The newest Glassdoor theme on this page, dated Nov 10, 2026: Employees report silos and operational disconnects between departments across multiple reviews. The overall rating in that row is 3.7 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Revvity been granted patents recently?
Yes. The newest grant on this page: Nov 10, 2026, Patents (Google Patents): Revvity Health Sciences was granted a patent for modular lab liquid handling.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →